BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
HIV infection
,
Stem cell
,
Holistic medicine
,
Doxorubicin
,
rs6983267
,
FGF21
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MAP2K1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Whole brain
Hippocampus
Temporal lobe
Frontal cortex
Parietal lobe
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Alpha-1-antitrypsin deficiency
Disorder of digestive system
Hepatocellular dysplasia
Tularemia
Poisoning by drug AND/OR medicinal substance
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Tween 80
Endothelin-1
Cholesterol
Bupropion
Mianserin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR206
SMNDC1
TLR2
ERCC6
Ptger4
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Role of Superoxide Reductase FA796 in Oxidative Stress Resistance in Filifactor alocis.
The disruption of the MAPKK gene triggering the synthesis of flavonoids in endophytic fungus Phomops…
Genome-wide identification and expression profiling of thes MAPK, MAPKK, and MAPKKK gene families in…
E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers.
Arabidopsis MAPKKK δ-1 is required for full immunity against bacterial and fungal infection.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant
Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer
Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterati…
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hema…
Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ